S178: SAFETY AND EFFICACY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH RD IN NEWLY DIAGNOSED, TRANSPLANT INELIGIBLE MULTIPLE MYELOMA PATIENTS: A PHASE 1/2 STUDY BY THE HELLENIC SOCIETY OF HEMATOLOGY

• E. Terpos,
• M. Gavriatopoulou,
• I. Ntanasis-Stathopoulos,
• P. Malandrakis,
• D. Fotiou,
• N. Kanellias,
• S. Gkolfinopoulos,
• K. Manousou,
• E. Kastritis,
• M.-A. Dimopoulos

Affiliations

E. Terpos

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

M. Gavriatopoulou

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

I. Ntanasis-Stathopoulos

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

P. Malandrakis

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

D. Fotiou

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

N. Kanellias

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

S. Gkolfinopoulos

2 Health Data Specialists, Dublin, Ireland

K. Manousou

2 Health Data Specialists, Dublin, Ireland

E. Kastritis

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

M.-A. Dimopoulos

1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece